Nā lāʻau anti-epileptic Medicine Grade Pharma Intermediate Hot sale Powder Tablets CAS 148553-50-8

                                               CAS 148553-50-8 Hoʻohana:

ʻO CAS 148553-50-8 kahi analog o ka neurotransmitter gamma-aminobutyric acid (GABA), i kūʻai ʻia ma lalo o ka inoa kālepa.I Kekemapa 2004, ua ʻae ka FDA i ka CAS 148553-50-8 ma ke ʻano he lāʻau lapaʻau no ka mālama ʻana i ka neuralgia diabetic a me ka herpes zoster neuralgia. ma luna o ʻelua ʻano ʻeha.I Iune 2005, ua ʻae ʻia ʻo CAS 148553-50-8 no ka mālama ʻana i ka maʻi epilepsy ʻokoʻa.Ma Malaki 2006, ua ʻae ka European Union i ka CAS 148553-50-8 no ka mālama ʻana i ka maʻi hopohopo nui (GAD) a me ka maʻi hopohopo pili kanaka (SAD).
              
Hoʻohana nui ʻia ʻo CAS 148553-50-8 no ka mālama ʻana i ka neuralgia peripheral a me ka mālama ʻana i nā ʻāpana ʻāpana kūloko.
Hiki i ka CAS 148553-50-8 ke hōʻemi i ka hoʻokuʻu ʻana i ka calcium-hilinaʻi o kekahi mau neurotransmitters ma o ka hoʻololi ʻana i ka hana kaila calcium.ʻOiai ʻo CAS 148553-50-8 he kumu hoʻohālike o ka inhibitory neurotransmitter γ-aminobutyric acid (GABA), ʻaʻole ia e hoʻopaʻa pololei i ka GABAA, GABAB, a i ʻole benzodiazepine receptors a ʻaʻole hoʻonui i ka GABAA i nā neurons moʻomeheu Pane, ʻaʻole i hoʻololi i ka. ka hoʻopaʻa ʻana o GABA i loko o ka lolo o nā ʻiole, a ʻaʻohe hopena koʻikoʻi i ka uptake a i ʻole degradation o GABA.Eia nō naʻe, ua ʻike ʻia ka haʻawina ʻo ka lōʻihi o ka hōʻike ʻana o nā neurons moʻomeheu i CAS 148553-50-8 hoʻonui i ka nui o nā mea lawe GABA a me ka helu o ka lawe ʻana i ka GABA hana.ʻAʻole ʻo CAS 148553-50-8 e ālai i nā kahawai sodium, ʻaʻohe hana ma nā mea hoʻokipa opioid, ʻaʻole e hoʻololi i ka hana cyclooxygenase, ʻaʻohe hana ma ka dopamine a me nā mea hoʻokipa serotonin, a ʻaʻole keʻakeʻa i ka reactivation o dopamine, serotonin, inest.